Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Low Birth Weight, Cumulative Obesity Dose, and the Risk of Incident Type 2 Diabetes.

Feng C, Osgood ND, Dyck RF.

J Diabetes Res. 2018 Jan 9;2018:8435762. doi: 10.1155/2018/8435762. eCollection 2018.

2.

The hefty fetal phenotype hypothesis revisited: high birth weight, type 2 diabetes and gestational diabetes in a Saskatchewan cohort of First Nations and non-First Nations women.

Dyck RF, Karunanayake C, Pahwa P, Osgood ND.

J Dev Orig Health Dis. 2019 Feb;10(1):48-54. doi: 10.1017/S2040174417000988. Epub 2017 Dec 22.

PMID:
29271332
4.

Anthropometric indices of First Nations children and youth on first entry to Manitoba/Saskatchewan residential schools-1919 to 1953.

Hackett FJ, Abonyi S, Dyck RF.

Int J Circumpolar Health. 2016 Jun 27;75:30734. doi: 10.3402/ijch.v75.30734. eCollection 2016.

5.

Do discrimination, residential school attendance and cultural disruption add to individual-level diabetes risk among Aboriginal people in Canada?

Dyck RF, Karunanayake C, Janzen B, Lawson J, Ramsden VR, Rennie DC, Gardipy PJ, McCallum L, Abonyi S, Dosman JA, Episkenew JA, Pahwa P; First Nations Lung Health Team.

BMC Public Health. 2015 Dec 9;15:1222. doi: 10.1186/s12889-015-2551-2.

6.

Persistent Albuminuria in Children with Type 2 Diabetes: A Canadian Paediatric Surveillance Program Study.

Sellers EA, Hadjiyannakis S, Amed S, Dart AB, Dyck RF, Hamilton J, Langlois V, Panagiotopoulos C, Dean HJ.

J Pediatr. 2016 Jan;168:112-7. doi: 10.1016/j.jpeds.2015.09.042. Epub 2015 Oct 23.

PMID:
26470688
7.

A community-based participatory research methodology to address, redress, and reassess disparities in respiratory health among First Nations.

Pahwa P, Abonyi S, Karunanayake C, Rennie DC, Janzen B, Kirychuk S, Lawson JA, Katapally T, McMullin K, Seeseequasis J, Naytowhow A, Hagel L, Dyck RF, Fenton M, Senthilselvan A, Ramsden V, King M, Koehncke N, Marchildon G, McBain L, Smith-Windsor T, Smylie J, Episkenew JA, Dosman JA.

BMC Res Notes. 2015 May 16;8:199. doi: 10.1186/s13104-015-1137-5.

8.

The long-term risks of end stage renal disease and mortality among First Nations and non-First Nations people with youth-onset diabetes.

Dyck RF, Jiang Y, Osgood ND.

Can J Diabetes. 2014 Aug;38(4):237-43. doi: 10.1016/j.jcjd.2014.03.005. Epub 2014 Jun 28.

PMID:
24986804
9.

A novel system dynamics model of female obesity and fertility.

Sabounchi NS, Hovmand PS, Osgood ND, Dyck RF, Jungheim ES.

Am J Public Health. 2014 Jul;104(7):1240-6. doi: 10.2105/AJPH.2014.301898. Epub 2014 May 15.

10.
11.

Decreased urine albumin:creatinine ratios in infants of diabetic mothers: does exposure to diabetic pregnancies alter fetal renal development?

Dyck RF, Bingham WT, Lim H, Jiang Y, Osgood ND.

J Dev Orig Health Dis. 2011 Oct;2(5):265-71. doi: 10.1017/S2040174411000286.

PMID:
25141263
12.

The inter- and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes.

Osgood ND, Dyck RF, Grassmann WK.

Am J Public Health. 2011 Jan;101(1):173-9. doi: 10.2105/AJPH.2009.186890.

13.

Differences in glycemic control and survival predict higher ESRD rates in diabetic First Nations adults.

Dyck RF, Sidhu N, Klomp H, Cascagnette PJ, Teare GF.

Clin Invest Med. 2010 Dec 1;33(6):E390-7.

PMID:
21134341
14.

Measuring quality of diabetes care by linking health care system administrative databases with laboratory data.

Klomp H, Dyck RF, Sidhu N, Cascagnette PJ, Teare GF.

BMC Res Notes. 2010 Aug 31;3:233. doi: 10.1186/1756-0500-3-233.

15.

Birth weight and risk of type 2 diabetes: a systematic review.

Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, Barrett-Connor E, Bhargava SK, Birgisdottir BE, Carlsson S, de Rooij SR, Dyck RF, Eriksson JG, Falkner B, Fall C, Forsén T, Grill V, Gudnason V, Hulman S, Hyppönen E, Jeffreys M, Lawlor DA, Leon DA, Minami J, Mishra G, Osmond C, Power C, Rich-Edwards JW, Roseboom TJ, Sachdev HS, Syddall H, Thorsdottir I, Vanhala M, Wadsworth M, Yarbrough DE.

JAMA. 2008 Dec 24;300(24):2886-97. doi: 10.1001/jama.2008.886. Review.

PMID:
19109117
16.

Activity and barriers in girls (8-16 yr) based on grade and maturity status.

Sherar LB, Gyurcsik NC, Humbert ML, Dyck RF, Fowler-Kerry S, Baxter-Jones AD.

Med Sci Sports Exerc. 2009 Jan;41(1):87-95. doi: 10.1249/MSS.0b013e31818457e6.

PMID:
19092703
17.

The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people.

Dyck RF, Klomp H, Marciniuk DD, Tan L, Stang MR, Ward HA, Hoeppner VH.

Can J Public Health. 2007 Jan-Feb;98(1):55-9.

PMID:
17278679
19.
20.

Renal transplantation in Saskatchewan.

Baltzan MA, Dyck RF.

CMAJ. 2000 Jul 25;163(2):159-60. No abstract available.

21.

Preventing NIDDM among aboriginal people: is exercise the answer? Description of a pilot project using exercise to prevent gestational diabetes.

Dyck RF, Sheppard MS, Cassidy H, Chad K, Tan L, Van Vliet SH.

Int J Circumpolar Health. 1998;57 Suppl 1:375-8.

PMID:
10093309
22.

Long-term renal graft failure declines with only azathioprine/steroid immunosuppression.

Baltzan MA Sr, Shoker AS, Dyck RF, Baltzan MA Jr.

Transplant Proc. 1998 Aug;30(5):1796-7. No abstract available.

PMID:
9723287
23.
24.

Non-diabetic end-stage renal disease among Saskatchewan aboriginal people.

Dyck RF, Tan L.

Clin Invest Med. 1998 Feb;21(1):33-8.

PMID:
9512883
27.

Gestational diabetes mellitus.

Edouard L, Dyck RF.

BMJ. 1993 Feb 27;306(6877):581-2. No abstract available.

28.

To screen or not to screen.

Dyck RF.

CMAJ. 1993 Jan 1;148(1):12; author reply 13-4. No abstract available.

29.

HLA matching enhances long-term renal graft survival but does not relate to acute rejection.

Baltzan MA, Baltzan RB, Baltzan BL, Cunningham TC, Pylypchuk GB, Dyck RF, West ML.

Medicine (Baltimore). 1990 Jul;69(4):227-31.

PMID:
2374507
30.

The response of plasma fibronectin to acute myocardial infarction in humans.

Dyck RF, Orchard RC, Senger DL.

Clin Invest Med. 1990 Jun;13(3):107-10.

PMID:
2114244
31.

Intravenous pulse methylprednisolone for the treatment of a child with Sjögren's nephropathy.

Rosenberg AM, Dyck RF, George DH.

J Rheumatol. 1990 Mar;17(3):391-4.

PMID:
2332864
32.

A modification of the urine osmolal gap: an improved method for estimating urine ammonium.

Dyck RF, Asthana S, Kalra J, West ML, Massey KL.

Am J Nephrol. 1990;10(5):359-62.

PMID:
2080786
33.

The effect of cyclosporine A on the acute phase response in mice and humans.

Dyck RF, Owen PS.

Transplant Proc. 1989 Apr;21(2):3317-8. No abstract available.

PMID:
2496505
35.

Quiz of the month. Pseudohyperkalemia and excessive K intake.

Dyck RF, West ML, Owen PS.

Am J Nephrol. 1988;8(4):305, 347-8. No abstract available.

PMID:
3189424
36.
37.

Fibronectin is an acute phase reactant in mice.

Dyck RF, Rogers SL.

Clin Invest Med. 1985;8(2):148-51.

PMID:
2421956
38.

Serum levels of C-reactive protein in neonatal respiratory distress syndrome.

Dyck RF, Bingham W, Tan L, Rogers SL.

Clin Pediatr (Phila). 1984 Jul;23(7):381-3.

PMID:
6723184
39.

Solid-phase immunoradiometric assay for serum amyloid A protein using magnetisable cellulose particles.

De Beer FC, Dyck RF, Pepys MB.

J Immunol Methods. 1982 Oct 29;54(2):213-21.

PMID:
7175191
40.

C-reactive protein in childhood dermatomyositis.

Haas RH, Dyck RF, Dubowitz V, Pepys MB.

Ann Rheum Dis. 1982 Oct;41(5):483-5.

41.

Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Fagan EA, Dyck RF, Maton PN, Hodgson HJ, Chadwick VS, Petrie A, Pepys MB.

Eur J Clin Invest. 1982 Aug;12(4):351-9.

PMID:
6814926
42.

Biology of serum amyloid P component.

Pepys MB, Baltz ML, de Beer FC, Dyck RF, Holford S, Breathnach SM, Black MM, Tribe CR, Evans DJ, Feinstein A.

Ann N Y Acad Sci. 1982;389:286-98. Review. No abstract available.

PMID:
7046582
43.

Amyloid P component is located on elastic fibre microfibrils in normal human tissue.

Breathnach SM, Melrose SM, Bhogal B, de Beer FC, Dyck RF, Tennent G, Black MM, Pepys MB.

Nature. 1981 Oct 22;293(5834):652-4. No abstract available.

PMID:
7290201
44.

Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis.

Breathnach SM, Bhogal B, Dyck RF, De Beer FC, Black MM, Pepys MB.

Br J Dermatol. 1981 Aug;105(2):115-24.

PMID:
7025878
45.

Agglutination of complement-coated erythrocytes by serum amyloid P-component.

Hutchcraft CL, Gewurz H, Hansen B, Dyck RF, Pepys MB.

J Immunol. 1981 Mar;126(3):1217-9.

PMID:
7462631
46.

Amyloid P-component is a constituent of normal human glomerular basement membrane.

Dyck RF, Lockwood CM, Kershaw M, McHugh N, Duance VC, Baltz ML, Pepys MB.

J Exp Med. 1980 Nov 1;152(5):1162-74.

47.

Amyloid P-component in human glomerular basement membrane. Abnormal patterns of immunofluorescent staining in glomerular disease.

Dyck RF, Evans DJ, Lockwood CM, Rees AJ, Turner D, Pepys MB.

Lancet. 1980 Sep 20;2(8195 pt 1):606-9.

PMID:
6159507
49.

Studies of human serum amyloid P-component (SAP) in relation to coagulation.

Pepys MB, Becker GJ, Dyck RF, McCraw A, Hilgard P, Merton RE, Thomas DP.

Clin Chim Acta. 1980 Jul 17;105(1):83-91. No abstract available.

PMID:
7398087
50.

C-reactive protein levels in systemic lupus erythematosus: a classification criterion?

Pereira Da Silva JA, Elkon KB, Hughes GR, Dyck RF, Pepys MB.

Arthritis Rheum. 1980 Jun;23(6):770-1. No abstract available.

PMID:
7387742

Supplemental Content

Support Center